Methadone Substitution Is Cost-Effective Option for Addressing HIV Epidemic in Ukraine
March 4, 2011
"Methadone substitution therapy is a highly cost-effective option for the growing mixed HIV epidemic in Ukraine," according to the authors of a PLoS Medicine article that compared "health care costs, quality-adjusted life years (QALYs), HIV prevalence, infections averted, and incremental cost-effectiveness" for interventions expanding methadone substitution therapy, increasing access to antiretroviral therapy, or a combination of the two. Based on their analysis, the authors report, "Offering methadone substitution therapy to 25% of IDUs reduced prevalence most effectively (to 53.1% IDUs, 0.80% non-IDUs), and was most cost-effective, averting 4,700 infections and adding 76,000 QALYs compared with no intervention at US$530/QALY gained" (Alistar et al., 3/1).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)